The Role of Tenecteplase vs. Alteplase, Neurological Focus

The role of tenecteplase in treating acute ischemic stroke has been evolving over the last several years. The practical advantages of using this agent, in addition to cost savings, are likely to increase its presence in a hospital setting where tenecteplase is to be added to the formulary. Clinicians who do not routinely practice in the emergency department or in the neurology setting may be less familiar with or unaware of the new data supporting its use. This session is designed to provide the audience with an evidence-based approach to the use of tenecteplase in patients suffering from acute ischemic stroke. New literature and current pharmacokinetic, administration, and dosing parameters associated with this medication will also be discussed. Program attendees of both BCCCP and BCPS specialties will benefit from the knowledge of the current literature addressed, which covers the use of thrombolytic therapy, overall treatment goals, and alternative agents. ​ 

​​ ​Role of Volatile Anesthetics in Critically Ill Patients, Perioperative Focus​​

Clinical pharmacists should understand the role of volatile anesthetics in critically ill patients outside of the operative setting. Pharmacists must be aware of how these drugs work, how they can be effectively delivered, and the risks and benefits of these agents compared with intravenous sedative agents.​ ​Speakers will analyze the mechanism of volatile anesthetics to induce general anesthesia and sedation, describe the properties that influence the drug's delivery to patients, and discuss and evaluate how the strategies to induce sedation have evolved over the last several years outside operating rooms. Speakers will further evaluate devices that can deliver anesthetics. As the role of these agents expands, pharmacists involved with sedation management must gain a proper understanding of this novel approach for their professional growth and development. ​